Greater Glasgow and Clyde Medicines
Key to symbols The medicine should be initiated by, or on the advice of a specialist, but is suitable for continuation by a GP The medicine should only be used and prescribed by a specialist Indicates the preferred choice within a class or group of medicines
The medicine should be initiated by, or on the advice of a specialist, but is suitable for continuation by a GP
The medicine should only be used and prescribed by a specialist
Indicates the preferred choice within a class or group of medicines
6.1.1. Insulins

6.1.1.1. Short-acting insulins

Preferred List
SOLUBLE INSULIN (ACTRAPID)

Restrictions:

Restricted to initiation by clinicians, either in primary care or the acute setting, experienced in the treatment of diabetes.

BNF Link

SOLUBLE INSULIN (HUMULIN S)

Restrictions:

Restricted to initiation by clinicians, either in primary care or the acute setting, experienced in the treatment of diabetes.

BNF Link

INSULIN ASPART

Restrictions:

Restricted to initiation by clinicians, either in primary care or the acute setting, experienced in the treatment of diabetes.

Prescribing Notes:

Insulin aspart preparations may differ in terms of speed of onset of action and should therefore be prescribed by brand name.

Different devices and presentations for administration of the same insulin may differ in cost.  When prescribing for the 1st time, use the most cost-effective device that best meets the patient's needs.

BNF Link

INSULIN LISPRO (HUMALOG) (injection)

Restrictions:

Restricted to initiation by clinicians, either in primary care or the acute setting, experienced in the treatment of diabetes.

Prescribing Notes:

Currently, only the 100 units/ml preparations have been considered and added to Formulary. Other strengths are currently non-Formulary

BNF Link

SOLUBLE INSULIN (INSUMAN RAPID)

Restrictions:

Restricted to initiation by clinicians, either in primary care or the acute setting, experienced in the treatment of diabetes.

BNF Link

Total Formulary
INSULIN GLULISINE (APIDRA) (injection)

Restrictions:

Restricted to initiation by clinicians, either in primary care or the acute setting, experienced in the treatment of diabetes and for use in patients where regular human soluble insulin is inappropriate.

BNF Link